Matt Dimond (@Matt_Dimond1) profile picture

MS-4 @LoyolaHealth, Clemson '21, Heart Failure Collaboratory, Inova Health System @hfcollaboratory

Joined July 2021
Photo by Matt Dimond (@Matt_Dimond1)Photo by Matt Dimond (@Matt_Dimond1)Photo by Matt Dimond (@Matt_Dimond1)
Huge congratulations again to the site-based research award recipients! Well deserved for their dedication to their respective fields 👏👏 👏
6
1
13
1,879
SIMULTANEOUS PUBLICATION OUT NOW🗣️ Click the link below to read Yasmire’s paper on clinical research’s unsung HEROES and the importance of rewarding site-based research ⬇️ ahajournals.org/doi/10.1161/… @dranulala @mfiuzat @coconnormd @MariellJessup @yasmireshardae
1
3
6
801
Me and @Matt_Dimond1 -so proud of you and what you have accomplished! @LoyolaStritch Catherine Kim plans to follow in his footsteps !
1
10
913
Congratulations @Matt_Dimond1 on completion of his research on factors associated with better BP control among physician patient panels. Turns out BP measurement method is a lot! @LoyolaStritch @LoyolaParkinson #stalbertsday @LoyolaChicago
2
1
2
685
Do BP control Quality Improvement (QI) initiatives work?? NEW @LoyolaHealth: ⬆️ physician AOBP measurement and ⬆️ 30-day patient follow up when BP is elevated = ⬆️ rates of physician #HTN control!! Huge thanks to @kramer_holly for her leadership on this project! #HTN #AOBP
Congratulations @Matt_Dimond1 on completion of his research on factors associated with better BP control among physician patient panels. Turns out BP measurement method is a lot! @LoyolaStritch @LoyolaParkinson #stalbertsday @LoyolaChicago
1
190
Feasibility and safety of apixaban in patients with an LVAD was evaluated in DOAC LVAD study. Results reported in #JACCHF @PalakShahMD @coconnormd
9
22
2,278
Incredible mentorship from @mfiuzat and all star ✨✨✨interns make for an incredible program @hfcollaboratory
1
2
158
How can we call attention to the lack of diversity in clinical trials at a Congressional level? @meghakgupta presents at #ACC2024 on the HFC Letter to Congress to reconsider demographic legislation and the HFC recommendations to enhance underrepresented enrollment in HF trials
6
10
1,167
How can we utilize community organizations to improve diversity in clinical trials? @iamyasdoll Presenting on how HFC and National Pan-Hellenic Councils can bring awareness to Black patients and underserved communities of the critical lack of diversity in HF clinical trials.
1
3
11
950
Great insights from @IsabellaCavagna at #ACC2024 today about the impact of #ClinicalTrial demographics on early adoption of breakthrough #MedTech. Now available in @JACCJournals: sciencedirect.com/science/ar… US Safety Info: bit.ly/3TVOnfL
4
12
1,631
Happy birthday to HFC Intern @meghakgupta 🎊🥳 What a great way to celebrate at your first ACC conference!
1
4
10
855
#SimPub in @JACCJournals Does HF trial enrollment contribute to underutilization of therapies among diverse groups in clinical practice? HFC Intern @IsabellaCavagna presents on Clinical Trial Inclusion manuscript out now at the link below🔗 sciencedirect.com/science/ar…
5
16
1,712
💡NEW State-of-the-Art Review on HFC’s efforts to train the next generation of members and create a standardized approach to data reporting, DMC conduct, & new member training to help address the growing demand for experienced DMC members Read below ⬇️ doi.org/10.1016/j.jchf.2024.…
2
6
552
HFC Special Focus meeting starting now… @coconnormd @mfiuzat @hmkyale @SnehaShahJain setting the stage for the meeting with the importance of #AI and how the HF community can embrace this groundbreaking technology
7
1
15
1,524
And that’s a wrap! ⁦@PalakShahMD⁩ closes #THT2024 with a BANG exploring promise & potential of #microRNA in #transplant #rejection ⁦@coconnormd⁩ ⁦@mpsotka⁩ ⁦@vbluml⁩ ⁦@ISHVnews⁩ ⁦@InovaHealth⁩ ⁦@InovaCVfellows⁩ ⁦@KiranKhush1⁩
9
1
30
3,736
Matt Dimond retweeted
#HFmrEF doesn’t exist: from a clinical context it adds unneeded confusion, from a research context it is an oversimplification of the continuous spectrum of LVEF.
1
3
14
1,943
The @ISHVnews Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study -- a Featured Late-Breaker at #THT To be presented by @PalakShahMD @crfheart @crfconferences
9
21
1,820
⁦@PalakShahMD⁩ shares #LBCT results #DOAC #LVAD pilot study #THT2024 Time now 4 pivotal RCT on anticoagulation in durable #MCS? ⁦@coconnormd⁩ ⁦@mpsotka⁩ ⁦@iyadisseh⁩ ⁦@MaryLoobyPharmD⁩ ⁦@ISHVnews⁩ ⁦@InovaHealth⁩ ⁦@InovaCVfellows⁩
2
14
1
45
5,267
A new model for training the next generation of clinical investigators, gap year HFC interns , Congrats ! – at Washington, DC
HFC Interns have FOUR abstracts accepted for presentation at the @ACCinTouch conference this spring in Atlanta, GA. Don’t forget to stop by the poster sessions 🎉 Specific times of presentations still to come @iamyasdoll @MeghaGu86063358 @IsabellaCavagna #ACC24
6
15
2,743
In #JACCHF REVIEW TOPIC OF THE MONTH, @Matt_Dimond1, @mpsotka, et al present results of @HFCollaboratory review of role of LVEF in categorization of HF, and provide recommendations for future of HF phenotyping jacc.org/doi/10.1016/j.jchf.…
5
13
1,554